📣 VC round data is live. Check it out!

Vicarious Surgical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vicarious Surgical and similar public comparables like PolarCool, Spineway, VibroSense Dynamics, CollPlant and more.

Vicarious Surgical Overview

About Vicarious Surgical

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.


Founded

2021

HQ

United States

Employees

123

Financials (FY)

Revenue: -
Net Income: -

EV

$8M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Vicarious Surgical Financials

Revenue (LTM)

Vicarious Surgical P&L

In the most recent fiscal year, Vicarious Surgical reported revenue of - and net income of -.

See analyst estimates for Vicarious Surgical
LTM2025202620272028
Net Profit($50M)($50M)

Financial data powered by Morningstar, Inc.

Vicarious Surgical Stock Performance

Vicarious Surgical has current market cap of $5M, and enterprise value of $8M.

Market Cap Evolution


Vicarious Surgical's stock price is $0.69.

Vicarious Surgical share price decreased by 90.8% in the last year.

See more trading valuation data for Vicarious Surgical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M$5M0.0%--4.2%-90.8%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Vicarious Surgical Valuation Multiples

Vicarious Surgical Financial Valuation Multiples

As of June 2, 2026, Vicarious Surgical has market cap of $5M and EV of $8M.

Vicarious Surgical has a P/E ratio of (0.1x).

LTM2025202620272028
P/E(0.1x)(0.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Vicarious Surgical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Vicarious Surgical Competitors

Vicarious Surgical competitors include PolarCool, Spineway, VibroSense Dynamics, CollPlant, Phase Holographic, SpectraCure, Inventionmed, Predict, ScandiDos and Lucyd.

Most Vicarious Surgical public comparables operate across Medical Devices, Automation & Robotics, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
PolarCool16.5x-(2.7x)-
Spineway0.2x0.2x(3.7x)(3.4x)
VibroSense Dynamics14.5x-(6.7x)-
CollPlant1.8x-(0.4x)-
Phase Holographic----
SpectraCure--(1.9x)-
Inventionmed8.0x-21.0x-
Predict0.5x-4.4x-

This data is available for Pro users. Sign up to see all Vicarious Surgical competitors and their valuation data.

Start Free Trial

Vicarious Surgical VC Funding History

Before going public, Vicarious Surgical raised $43M in total equity funding, across 4 rounds.


Vicarious Surgical Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Aug-20Series AAbenteuer Ventures; AME Cloud Ventures; Bill Gates; Bossa Invest; E15 VC; Innovation Endeavors; Khosla Ventures$13M-Vicarious Surgical is a Boston-area surgical robotics company developing an intelligent, single-incision robotic platform that combines miniaturized robotics, computer vision, and 3D visualization to perform minimally invasive surgery. The system features arms with 9 degrees of freedom per arm and 360-degree visualization through a 1.5 cm incision, designed to improve surgical efficiency and patient outcomes while reducing healthcare costs compared to existing robot-assisted surgery systems. In August 2020, the company closed a $13.2 million funding round led by E15 Capital, with participation from existing investors including Bill Gates, Khosla Ventures, Innovation Endeavors, and AME Cloud Ventures. E15 Capital's Managing Director Philip Liang and Ric Fulop, founding CEO of Desktop Metal, joined the company's Board of Directors as part of the round. At the time of this funding, Vicarious Surgical was approaching clinical use of its first product and had received FDA breakthrough device designation, with plans to file a de novo application for ventral hernia repair procedures. The capital was intended to further develop the surgical robotics platform and support the company's regulatory pathway toward commercialization.
Feb-19Series AAME Cloud Ventures; Gates Frontier Fund; Innovation Endeavors; Khosla Ventures; Marc Benioff$10M-Vicarious Surgical raised $10 million in February 2019 led by Gates Frontier Fund, with participation from Khosla Ventures, Innovation Endeavors, and other investors. The company had raised approximately $31.8 million cumulatively by this point to develop its miniaturized robotics and virtual reality surgical platform. The technology enables surgeons to perform minimally invasive procedures through a single 1.5 cm incision with 360-degree visualization inside the abdominal cavity. At the time of this funding, Vicarious Surgical was still in the development and testing phase, conducting laboratory tests and FDA application preparations, with no commercial revenue. The company would later pursue a public listing through a SPAC merger with D8 Holdings in 2023, targeting a $1.1 billion post-money valuation and $425-460 million in total capital, with initial commercial launch planned for late 2023 focused on ventral hernia repair procedures.
Apr-18Series AAME Cloud Ventures; Gates Ventures; Innovation Endeavors; Khosla Ventures; Marc Benioff$17M-Vicarious Surgical Inc. is a surgical robotics company founded in 2014 that develops single-port robotic surgery systems. The company's technology uses proprietary decoupled actuators and immersive reality to enable minimally invasive surgery through a single incision, and was granted FDA Breakthrough Device Designation. The company has since raised over $50 million across multiple funding rounds and went public on the OTC market (RBOT). As of fiscal 2025, the company remains unprofitable with negative net income of $50.2 million, though the company continues to develop its surgical robotics platform for commercial deployment.
Oct-16SeedKhosla Ventures$3M-Vicarious Surgical, a Cambridge, Mass.-based company founded in 2014, develops miniaturized robotics and immersive virtual reality to enable surgeons to perform minimally invasive surgery through a single micro-incision. The platform aims to shrink the surgeon inside the patient for improved visibility and accuracy. Khosla Ventures supported an $800,000 seed raise in October 2016, following a $2.4 million raise earlier that year. Khosla Ventures participated as a lead investor in the subsequent $16.75 million Series A round announced April 17, 2018, alongside Innovation Endeavors, Gates Ventures, AME Cloud Ventures, and Marc Benioff. The Series A brought total funding to $19.8 million across three rounds and funded team expansion and technology development. Khosla Ventures' Samir Kaul noted the progress from proof-of-concept in the 2016 seed to Series A advancements. The company later pursued a SPAC merger in 2021 targeting a $1.1 billion valuation and up to $460 million raise.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Vicarious Surgical

When was Vicarious Surgical founded?Vicarious Surgical was founded in 2021.
Where is Vicarious Surgical headquartered?Vicarious Surgical is headquartered in United States.
How many employees does Vicarious Surgical have?As of today, Vicarious Surgical has over 123 employees.
Who is the CEO of Vicarious Surgical?Vicarious Surgical's CEO is Stephen From.
Is Vicarious Surgical publicly listed?Yes, Vicarious Surgical is a public company listed on OTC Pink Sheets.
What is the stock symbol of Vicarious Surgical?Vicarious Surgical trades under RBOT ticker.
When did Vicarious Surgical go public?Vicarious Surgical went public in 2021.
Who are competitors of Vicarious Surgical?Vicarious Surgical main competitors include PolarCool, Spineway, VibroSense Dynamics, CollPlant, Phase Holographic, SpectraCure, Inventionmed, Predict, ScandiDos, Lucyd.
What is the current market cap of Vicarious Surgical?Vicarious Surgical's current market cap is $5M.
Is Vicarious Surgical profitable?No, Vicarious Surgical is not profitable.
What is the current net income of Vicarious Surgical?Vicarious Surgical's last 12 months net income is ($50M).
How many companies Vicarious Surgical has acquired to date?Vicarious Surgical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Vicarious Surgical has invested to date?Vicarious Surgical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Vicarious Surgical

Lists including Vicarious Surgical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial